HPLC Testing, Method Development and GLP Validation by PhDs at 20+ Year, FDA-Inspected Lab

HPLC method validation is a recognized and efficient way to determine the suitability of the assay method to provide relevant data to confirm that the process or the HPLC testing gives acceptable and reliable results within the scope of the process. The most widely applied HPLC method validation characteristics are accuracy, precision (repeatability and intermediate precision), specificity, detection limit, quantitation limit, linearity, range, robustness, and stability of analytical resolutions.

High-Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) are both liquid chromatography procedures used to separate and detect the different components found in complex mixtures. However, UPLC operates at higher pressures (~15,000 psi) and permits for smaller particle sizes in columns, while HPLC operates at lower pressures (max <6000 psi). UPLC shows higher analyte resolution and sensitivity, and uses less solvents, and shorter run times. In contrast, HPLC analysis consumes more solvent with less sample throughput, but the hardware costs less.

The HPLC analysis of small molecules is most often performed in reversed-phase separation mode. Hydrophilic interaction chromatography (HILIC) and normal-phase chromatography are also suitable for separating polar compounds, with HILIC being the preferred method. Ion chromatography can also separate ionic compounds, ion-exchange separation modes, and inorganic anions or cations.

HPLC testing separates, identifies and quantifies drugs, impurities and related substances in formulations, raw materials and biological samples. The offer here spans assay and purity by HPLC-UV and DAD, fluorescence detection where it buys sensitivity, actives and content quantitation, impurity profiling, stability-indicating methods, and dose formulation analysis, with method development and GLP validation to ICH Q2 behind all of it.

The System Suitability Test (SST) is used to verify that an analytical method was suitable for its intended purpose of the day for the analysis was done. It is an essential parameter to ensure the quality of the process for correct measurements. Each SST is specific to a method with predefined acceptance criteria for certain parameters, e.g., absorbance values between 0.2 and 1.0 for a photometric content determination method or some resolution factors for chromatographic techniques. System suitability proves that the system is working flawlessly before the analysis on HPLC or any other system, and it is required to be done before every sample analysis.

Dose formulation verification is mandatory for GLP toxicology, and HPLC is usually the right instrument for it: formulation concentrations are high, matrices are clean, and UV or fluorescence detection quantifies them accurately without mass spectrometry’s cost. NorthEast BioLab validates the method in your actual vehicle, samples homogeneity across the container, and runs stability across the dosing window; the full offer lives on the Dose Formulation Analysis page linked from this one.

Because a formulation that degrades between preparation and dosing quietly invalidates the study built on it. Stability testing by HPLC tracks the test article at the storage condition, at room temperature during handling, and across the dosing period, with a stability-indicating method proven by forced degradation so degradants resolve from the parent instead of hiding underneath it. The Dose Formulation Analysis page carries the complete workflow.

HPLC method development shows that the developed chromatography method is suitable for its intended use in the development and manufacturing of pharmaceutical drug ingredients and drug products. The fundamental separation techniques and principles involved in the analytical method development using the HPLC and UPLC are a selection of chromatography mode, detector, column (stationary phase), mobile phase, organic modifiers, ion-pair reagents, flow rate, solvent delivery system (elution mode), diluent, methods of extraction, samples to be used, experimentation to finalize the procedure, selection of test concentration and injection volume, forced degradation studies (stress resting), evaluation of stress testing Mass balance study, finalization of wavelengths, stability of the solution, system suitability, robustness of the method, relative response factor, quantification methods.

If the analyte sits at a decent concentration in a clean matrix, HPLC with UV or fluorescence detection answers the question at a fraction of the cost, and we quote exactly that. Low concentrations, dirty matrices and co-eluting interferences are where detection by mass spectrometry earns its price. The honest escalation is the whole premise of this page, and both ends of the ladder run in this building.

Yes, and transfer is faster and cheaper than redevelopment. Send the method, its validation state and recent chromatograms; we verify it on our systems, name any gap in writing, and only then talk about study samples. A working method is an asset; we treat it like one.

Forced degradation stresses the drug, heat, light, acid, base, oxidation, to generate the degradants your method must be able to see. A stability-indicating method proves the degradants resolve from the parent peak instead of hiding underneath it. Without that proof, a stability study can pass while the product quietly fails, which is why the method comes first and the timepoints second.

When the analyte fluoresces, natively or through derivatization, fluorescence detection buys one to three orders of magnitude in sensitivity over UV without moving to mass spectrometry, and it adds selectivity because few co-eluting compounds fluoresce at the same wavelengths. It is the middle rung of the ladder on this page: cheaper than LC-MS/MS, more sensitive than UV, and we quote it whenever it honestly fits.